1 Takeshi Takaku, Yoshiyuki Kimura, Hiromichi Okuda.Isola- tion of an antitumor compound from agaricus blazei murill and its mechanism of action[J].J Nutr, 2001;131(5):1409-13 2 Ravaud A, Chevreau C, Cany L, Houyau P, Dohollou N, Roche H, et al.Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens:results of a Randomized Phase III Trial[J].J Clin Onco, 1998;6(9):2930-6 3 Abramovich D, Bolwell B, Pohlman B, Abramovich D, Bolwell B, Pohlman B, et al.Low-dose granulocyte-macrophoge colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are well tolerated following autologous stem cell transplant (ASCT) in patients with hematologic malignancies[J].Oncotherapy, 1999;1(2):11 4 Gjertsen MK, Buanes T, Rosseland AR, Bakka A, Gladhaug I, Soreide O, et al.Intradermal RAS peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: clinical and immunological responses in patients with pancreatic adenocarcinoma[J].Int J Cancer, 2001;92(3):441-50 5 Brown AL, Dunsford TH, Jarrett O, Willett BJ, Hosie MJ. Demonstration of biological activity of CD40 ligand (CD154) in the domestic cat[J].Cytokine, 2002;17(3):140-8 6 Michael J, Mastrangelo, Henry C, Maguire Jr, Laurence C, Eisenlohr, et al.Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma[J].Cancer Gene Therapy, 1998;6(5):159-70 7 Johnson BS, Mueller L.The cytokines IL-3 and GM-CSF regulate the transcriptional activity of retinoic acid receptors in different in vitro models of myeloid differentiation[J].Blood, 2002; 99(3):746-53 8 Jean-Luc Raoul, Bernard Cadre, Elisabeth Le Prise, Boucher E.Local injections of GM-CSF for the treatment of radiation-induced mucosa ulcers[J].Radio Onco, 2003;68(3):303-4 |